- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Re-examine JnJ baby powder samples: HC directs Maharashtra govt
"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution,” the court said.
Mumbai: The Bombay High Court on Monday directed the Maharashtra government to re-examine samples of baby powder manufactured by Johnson & Johnson Pvt Ltd in government or government-approved laboratories.
A division bench of Justices S V Gangapurwala and S G Dige asked additional government leader Milind More to submit names on November 16 of such labs where the tests can be conducted.
The order was passed while hearing a petition filed by the company challenging two orders of the state government, one dated September 15 cancelling the licence and the second dated September 20 ordering an immediate stop to the manufacturing and sale of the company's baby powder product.
The orders were passed by the Joint Commissioner and Licensing Authority of the state Food and Drug Administration (FDA).
The state government had based its orders on the report of the Central Drug Laboratory, which found the powder contained higher pH level than prescribed.
The HC, on Monday, also asked the state to take instructions on whether they would be willing to allow the company to begin manufacturing of the powder at the facility.
"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution," the court said.
The company, in its plea, said 14 random batches of February, March, and September 2022 were tested by an independent public testing laboratory and all were found to be well within the prescribed pH value.
The leading fast-moving consumer goods (FMCG) manufacturer said it has been making baby powder in its Mulund plant for the last 57 years and its licence was renewed in January 2020. The company said it was facing a daily loss of Rs 2.5 crore, based on market value of goods sold, due to revocation of licence.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story